WO2004098636A3 - Vaccinating against infectious diseases using proteosomes - Google Patents
Vaccinating against infectious diseases using proteosomes Download PDFInfo
- Publication number
- WO2004098636A3 WO2004098636A3 PCT/US2004/014236 US2004014236W WO2004098636A3 WO 2004098636 A3 WO2004098636 A3 WO 2004098636A3 US 2004014236 W US2004014236 W US 2004014236W WO 2004098636 A3 WO2004098636 A3 WO 2004098636A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteosomes
- infectious diseases
- against infectious
- vaccinating against
- vaccinating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006514314A JP2006525373A (en) | 2003-05-05 | 2004-05-05 | Vaccination against infectious diseases using proteosomes |
EP04760725A EP1622641A2 (en) | 2003-05-05 | 2004-05-05 | Vaccinating against infectious diseases using proteosomes |
AU2004235815A AU2004235815A1 (en) | 2003-05-05 | 2004-05-05 | Vaccinating against infectious diseases using proteosomes |
CA002524485A CA2524485A1 (en) | 2003-05-05 | 2004-05-05 | Vaccinating against infectious diseases using proteosomes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46762403P | 2003-05-05 | 2003-05-05 | |
US60/467,624 | 2003-05-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004098636A2 WO2004098636A2 (en) | 2004-11-18 |
WO2004098636A3 true WO2004098636A3 (en) | 2005-05-19 |
WO2004098636A8 WO2004098636A8 (en) | 2005-08-18 |
Family
ID=33435094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/014236 WO2004098636A2 (en) | 2003-05-05 | 2004-05-05 | Vaccinating against infectious diseases using proteosomes |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1622641A2 (en) |
JP (1) | JP2006525373A (en) |
AU (1) | AU2004235815A1 (en) |
CA (1) | CA2524485A1 (en) |
WO (1) | WO2004098636A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7255867B2 (en) | 2002-11-15 | 2007-08-14 | Id Biomedical Corporation Of Quebec | Vaccine |
JP4966661B2 (en) | 2003-10-22 | 2012-07-04 | アイディー バイオメディカル コーポレイション オブ ケベック | Compositions and methods for activating innate and allergic immunity |
EP2068834A2 (en) * | 2006-09-08 | 2009-06-17 | Becton, Dickinson & Company | Stable powder formulations of aluma-dsorbed vaccines |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001045639A2 (en) * | 1999-12-22 | 2001-06-28 | The Ohio State University Research Foundation | Methods for protecting against lethal infection with bacillus anthracis |
WO2002072012A2 (en) * | 2001-03-09 | 2002-09-19 | Id Biomedical Corporation Of Quebec | A novel proteosome-liposaccharide vaccine adjuvant |
-
2004
- 2004-05-05 CA CA002524485A patent/CA2524485A1/en not_active Abandoned
- 2004-05-05 AU AU2004235815A patent/AU2004235815A1/en not_active Abandoned
- 2004-05-05 WO PCT/US2004/014236 patent/WO2004098636A2/en not_active Application Discontinuation
- 2004-05-05 JP JP2006514314A patent/JP2006525373A/en not_active Withdrawn
- 2004-05-05 EP EP04760725A patent/EP1622641A2/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001045639A2 (en) * | 1999-12-22 | 2001-06-28 | The Ohio State University Research Foundation | Methods for protecting against lethal infection with bacillus anthracis |
WO2002072012A2 (en) * | 2001-03-09 | 2002-09-19 | Id Biomedical Corporation Of Quebec | A novel proteosome-liposaccharide vaccine adjuvant |
Also Published As
Publication number | Publication date |
---|---|
AU2004235815A1 (en) | 2004-11-18 |
CA2524485A1 (en) | 2004-11-18 |
WO2004098636A2 (en) | 2004-11-18 |
WO2004098636A8 (en) | 2005-08-18 |
JP2006525373A (en) | 2006-11-09 |
EP1622641A2 (en) | 2006-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002080965A3 (en) | Vaccine composition | |
WO2004080398A3 (en) | 1-amino 1h-imidazoquinolines | |
WO2003072035A8 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004041170A9 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004094596A8 (en) | Novel immunogenic compositions for the prevention and treatment of meningococcal disease | |
PL351893A1 (en) | Vaccines | |
WO2003002136A3 (en) | Stable formulation of modified glp-1 | |
WO2004024097A9 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
ATE413188T1 (en) | HUMAN PAPILLOMAVIRUS VACCINE FORMULATIONS | |
AU2002324914A1 (en) | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith | |
ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
WO2004091572A3 (en) | Cochleate compositions directed against expression of proteins | |
AU2001241918A1 (en) | Methods of enhancing activity of vaccines and vaccine compositions | |
AU2002312303A1 (en) | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease | |
AU2003236156A1 (en) | Pharmaceutical compositions used for immune disease treatment and improvement | |
AU2003282498A1 (en) | Hiv vaccine formulations | |
EP1583506A3 (en) | Eye-drop vaccine containing copolymer 1 for therapeutic immunization | |
EP1534295A4 (en) | Formulations and methods of administration of cephalotaxines, including homoharringtonine | |
AU2002359618A1 (en) | Medicinal compositions and therapeutic methods | |
WO2001070265A3 (en) | Lipopeptide adjuvants | |
WO2004030631A3 (en) | Anti-cancer and anti-infectious disease compositions and methods for using same | |
WO2004024076A8 (en) | Novel compositions and methods for the treatment of immune related diseases | |
WO2004098636A8 (en) | Vaccinating against infectious diseases using proteosomes | |
EP1594531A4 (en) | Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page |
Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2524485 Country of ref document: CA Ref document number: 2006514314 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004235815 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004760725 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2004235815 Country of ref document: AU Date of ref document: 20040505 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004235815 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004760725 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2004760725 Country of ref document: EP |